scholarly article | Q13442814 |
P50 | author | Rille Pullerits | Q57383900 |
Helena Forsblad-d'Elia | Q57414181 | ||
P2093 | author name string | M Bokarewa | |
H Carlsten | |||
P2860 | cites work | FIZZ1, a novel cysteine-rich secreted protein associated with pulmonary inflammation, defines a new gene family | Q24630827 |
Physiologic role of interleukin-1 receptor antagonist | Q24791076 | ||
Interleukin-1 receptor antagonist: role in biology | Q28271409 | ||
The hormone resistin links obesity to diabetes | Q29616100 | ||
Resistin release by human adipose tissue explants in primary culture | Q34167768 | ||
Serum Resistin (FIZZ3) Protein Is Increased in Obese Humans | Q34275027 | ||
Radiographic joint destruction in postmenopausal rheumatoid arthritis is strongly associated with generalised osteoporosis | Q35552836 | ||
Changes in plasma levels of fat-derived hormones adiponectin, leptin, resistin and visfatin in patients with rheumatoid arthritis. | Q35637875 | ||
The current biology of resistin | Q35721044 | ||
Resistin in rheumatoid arthritis synovial tissue, synovial fluid and serum | Q35760141 | ||
Role of resistin as a marker of inflammation in systemic lupus erythematosus | Q36641497 | ||
A cysteine-rich adipose tissue-specific secretory factor inhibits adipocyte differentiation | Q38525147 | ||
Serum resistin is associated with high risk in patients with congestive heart failure--a novel link between metabolic signals and heart failure | Q40230312 | ||
Resistin is expressed in pancreatic islets | Q40629715 | ||
A multicenter, double-blind, dose-ranging, randomized, placebo-controlled study of recombinant human interleukin-1 receptor antagonist in patients with rheumatoid arthritis: radiologic progression and correlation of Genant and Larsen scores | Q41736717 | ||
Plasma and urine levels of resistin and adiponectin in chronic kidney disease | Q42510116 | ||
Resistin is expressed in human macrophages and directly regulated by PPAR gamma activators | Q44263788 | ||
Serum resistin levels in women taking combined oral contraceptives containing desogestrel or gestodene | Q44906151 | ||
The relationship between serum resistin, leptin, adiponectin, ghrelin levels and bone mineral density in middle-aged men. | Q46629440 | ||
Increased serum resistin in nonalcoholic fatty liver disease is related to liver disease severity and not to insulin resistance. | Q46880188 | ||
A polymorphism in the resistin gene promoter is related to increased C-reactive protein levels in patients with coronary artery disease | Q46959457 | ||
Genetic and environmental determinants of circulating resistin level in a community-based sample | Q47817977 | ||
A comparison of oral and transdermal short-term estrogen therapy in postmenopausal women with metabolic syndrome. | Q51486613 | ||
Body fat mass and macronutrient intake in relation to circulating soluble leptin receptor, free leptin index, adiponectin, and resistin concentrations in healthy humans. | Q51537232 | ||
Plasma resistin levels correlate with determinants of the metabolic syndrome. | Q51922716 | ||
P433 | issue | 7 | |
P921 | main subject | rheumatoid arthritis | Q187255 |
anakinra | Q415411 | ||
P304 | page(s) | 1082-1087 | |
P577 | publication date | 2008-05-29 | |
P1433 | published in | Rheumatology | Q7320492 |
P1476 | title | Resistin in serum is associated with higher levels of IL-1Ra in post-menopausal women with rheumatoid arthritis | |
P478 | volume | 47 |
Q45787030 | A study of the link between bone turnover markers and bone mineral density with inflammation and body mass in postmenopausal women with active rheumatoid arthritis |
Q33950766 | Adipocytokines are associated with radiographic joint damage in rheumatoid arthritis. |
Q37845275 | Adipocytokines as driving forces in rheumatoid arthritis and related inflammatory diseases? |
Q37700750 | Adipokines as potential biomarkers in rheumatoid arthritis |
Q38808869 | Adipokines in bone disease |
Q36353577 | Adipokines in psoriatic arthritis patients: the correlations with osteoclast precursors and bone erosions |
Q34228799 | Adipokines: biofactors from white adipose tissue. A complex hub among inflammation, metabolism, and immunity |
Q64119496 | Associations between Adipokines in Arthritic Disease and Implications for Obesity |
Q26864855 | Beyond fat mass: exploring the role of adipokines in rheumatic diseases |
Q58758244 | Carnosine Supplementation Improves Serum Resistin Concentrations in Overweight or Obese Otherwise Healthy Adults: A Pilot Randomized Trial |
Q55027042 | Chronic Pain in Inflammatory Arthritis: Mechanisms, Metrology, and Emerging Targets-A Focus on the JAK-STAT Pathway. |
Q37300823 | Common inflammatory mediators orchestrate pathophysiological processes in rheumatoid arthritis and atherosclerosis |
Q46149920 | Elevated serum resistin in juvenile idiopathic arthritis: relation to categories and disease activity. |
Q35714031 | Human adipose-derived mesenchymal stem cells attenuate collagen antibody-induced autoimmune arthritis by inducing expression of FCGIIB receptors |
Q35811386 | Interactions between Serum Adipokines and Osteocalcin in Older Patients with Hip Fracture |
Q47931115 | Resistin as an inflammatory marker in patients with schizophrenia treated with clozapine |
Q33994903 | Resistin decreases expression of endothelial nitric oxide synthase through oxidative stress in human coronary artery endothelial cells |
Q86313523 | Resistin in inflammatory and degenerative rheumatologic diseases. Relationship between resistin and rheumatoid arthritis disease progression |
Q51483437 | Resistin is linked to inflammation, and leptin to metabolic syndrome, in women with inflammatory arthritis. |
Q47653637 | Rheumatoid arthritis and periodontal disease: What are the similarities and differences? |
Q27008359 | Role of adipokines in atherosclerosis: interferences with cardiovascular complications in rheumatic diseases |
Q46167805 | Serum and synovial adiponectin, resistin, and visfatin levels in rheumatoid arthritis patients. Relation to disease activity |
Q40984407 | Serum resistin levels in patients with rheumatoid arthritis and systemic lupus erythematosus: a meta-analysis. |
Q57744497 | Temporal relationship between serum adipokines, biomarkers of bone and cartilage turnover, and cartilage volume loss in a population with clinical knee osteoarthritis |
Q92825085 | The Adipokine Network in Rheumatic Joint Diseases |
Q36095970 | The role of adipokines in connective tissue diseases. |
Q38099557 | The role of resistin in inflammatory myopathies. |
Q36148660 | Treatment-specific changes in circulating adipocytokines: a comparison between tumour necrosis factor blockade and glucocorticoid treatment for rheumatoid arthritis |
Q37909903 | What's new in our understanding of the role of adipokines in rheumatic diseases? |
Search more.